Cinsiyet
Verilen QTc uzatan ilaç sayısı
If receiving ≥2 drugs, patient receives 3 points for 1 QTc-prolonging drug as well as 3 additional points for ≥2
Sonuç
Parametreleri doldurup "Hesapla" butonuna basın.
Always consider that higher risk may develop depending on clinical course and drug interactions and pharmacokinetics.
Consider consultation with pharmacist, adjusting risk factors as much as possible. EKG should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc.
Consider consultation with pharmacist, adjusting risk factors as much as possible, and using alternative medications if possible. EKG should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc.
Bu hesaplayıcı doğru çalıştı mı?